Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China

ConditionType 1 Diabetes Mellitus

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age3-75

SponsorThird Affiliated Hospital, Sun Yat-Sen University

About this trial

This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the glycemic efficacy and potential related factors of the open-source APS.

Eligibility criteria

Qualifiers

diagnosed T1DM.

Currently use open-source APS for at least 3 months.

Willing and able to provide informed consent (or be a parent or other legally authorized representative) and to provide the data.

reside in China.

Disqualifiers

None

Trial design

Treatments tested in this trial

open-source APS;

Treatment groups

500 Participants

are divided into 1 treatment group

Sponsors and collaborators

Third Affiliated Hospital, Sun Yat-Sen University

Lead sponsor

Source ClinicalTrials.gov